Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Thoracic Cancer
|
May 4, 2021
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata, et al.
Thoracic Cancer
|
September 7, 2020
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer
Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Anticancer Research
|
June 29, 2026
Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis
Sousuke Kubo, Kohei Somekawa, Satoshi Nagaoka, et al.
Thoracic Cancer
|
March 28, 2023
Primary tracheal small-cell carcinoma detected 11 months after surgery for pulmonary large-cell neuroendocrine carcinoma: A case report
Chihiro Sugimoto, Shuhei Teranishi, Tomoe Sawazumi, et al.
Thoracic Cancer
|
March 20, 2023
Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report
Shuntaro Hiro, Shuhei Teranishi, Tomoe Sawazumi, et al.
BMC Cancer
|
October 3, 2022
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, et al.
Scientific Reports
|
July 2, 2024
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, et al.
Plos One
|
August 1, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse
Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi, et al.
Thoracic Cancer
|
August 2, 2023
Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma
Nobuyuki Hirama, Masaki Yamamoto, Satoshi Nagaoka, et al.
Thoracic Cancer
|
December 6, 2021
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial
Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Thoracic Cancer
|
May 4, 2021
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata, et al.
Thoracic Cancer
|
September 7, 2020
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer
Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Anticancer Research
|
June 29, 2026
Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis
Sousuke Kubo, Kohei Somekawa, Satoshi Nagaoka, et al.
Thoracic Cancer
|
March 28, 2023
Primary tracheal small-cell carcinoma detected 11 months after surgery for pulmonary large-cell neuroendocrine carcinoma: A case report
Chihiro Sugimoto, Shuhei Teranishi, Tomoe Sawazumi, et al.
Thoracic Cancer
|
March 20, 2023
Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report
Shuntaro Hiro, Shuhei Teranishi, Tomoe Sawazumi, et al.
BMC Cancer
|
October 3, 2022
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study
Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, et al.
Scientific Reports
|
July 2, 2024
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan
Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, et al.
Plos One
|
August 1, 2024
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse
Hiromi Matsumoto, Taichi Fukushima, Nobuaki Kobayashi, et al.
Thoracic Cancer
|
August 2, 2023
Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma
Nobuyuki Hirama, Masaki Yamamoto, Satoshi Nagaoka, et al.
Thoracic Cancer
|
December 6, 2021
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial
Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa, et al.
Page
of 3